Panchkula, Haryana
GST No. 06ABHFM9351J1ZW
Respule
Our product range includes a wide range of levosulbutamol 1.25mg + ipratropium 500mcg.Levosulbutamol 1.25MG + Ipratropium 500MCG
Approx. Rs 730 / PieceGet Latest Price
Product Details:| Strength | 1.25 mg |
| Pack Size | 4*5*2.5 ml |
| Sterility | Sterile |
| Packaging Size | 4*5*2.5ml |
| Brand | Levosulbutamol 1.25MG + Ipratropium 500MCG iv infusion |
| Usage | Asthma |
| Prescription/Non prescription | Prescription |
| Also gives | PCD Pharma |
| Shelf life | 24 months |
| Country of Origin | Made in India |
Levosulbutamol 1.25MG + Ipratropium 500MCG
Levosulbutamol 1.25 mg + Ipratropium 500 mcg Nebuliser Solution is a combination therapy designed for fast and effective relief of bronchospasm in patients with asthma and chronic obstructive pulmonary disease (COPD).
-
Levosulbutamol is a selective β2-adrenergic receptor agonist that relaxes bronchial smooth muscles, providing rapid bronchodilation.
-
Ipratropium Bromide is an anticholinergic agent that blocks vagal-mediated bronchoconstriction, enhancing and prolonging bronchodilation.
This dual-action nebuliser ensures faster onset and longer-lasting relief of respiratory distress, suitable for both adults and pediatric patients.
Key Benefits- Rapid bronchodilation and symptom relief
- Dual-action therapy for better airway management
- Easy administration via nebuliser
- Effective in both acute and maintenance therapy
- Safe for adults and children
- Enhances patient compliance
Explore More Products
Criticine Care (Trademark Of Mcbrex Lifesciences)
Panchkula - 134113, Haryana, India
© Criticine Care (Trademark Of Mcbrex Lifesciences). All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited